Search Results 1041-1050 of 11268 for Antifungal Resistance

  1. B-Cell Lymphoma Clinical Trials - Mayo Clinic Research

    This study is being performed to understand the causes of drug resistance and to improve the treatment options for patients diagnosed with B-cell cancers. We ...

  2. Medical Research & Education - Mayo Clinic News Network

    Mayo Clinic researchers identify molecule linked to treatment-resistant inflammatory bowel disease featured image. Research. Mayo Clinic researchers identify ...

  3. Gram-Negative Bloodstream Infection Management Via Oral Antibiotic Therapy Trial - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  4. A Phase 1b Trial Of ATRC-101 In Adults With Advanced Solid Malignancies - Mayo Clinic

    Infection requiring intravenous antibacterial, antiviral, or antifungal therapy within 2 weeks prior to the planned first dose of investigational product.

  5. Metastatic (stage 4) prostate cancer - Symptoms and causes - Mayo Clinic

    Accessed Jan. 15, 2025. Dawson NA, et al. Overview of the treatment of castration-resistant prostate cancer (CRPC). https://www.uptodate.com/contents/search.

  6. A Phase I Study Of MSB2311 In Advanced Solid Tumors - Mayo Clinic

    This is a phase I study to determine the safety and toxicity, PK/PD, immunogenicity, biomarkers, anti-tumor activity and establish a preliminary recommended ...

  7. PR3-AAV Resilient Remission Or PRRR - Mayo Clinic

    The purpose of this study is to determine the proportion of patients achieving both complete remission and seronegativity for Anti-Neutrophil Cytoplasmic ...

  8. HLA-Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation With Reduced Dose Post Transplantation Cyclophosphamide GvHD Prophylaxis - Mayo Clinic

    Uncontrolled bacterial, viral, or fungal infection at the time of ... resistance panels are negative, the patient is compliant with ART, and their disease

  9. A Placebo-Controlled Study Of Oral Ozanimod As Maintenance Therapy For Moderately To Severely Active Crohn's Disease - Mayo Clinic

    Subject is receiving treatment with breast cancer resistance protein (BCRP) inhibitors (e.g., cyclosporine, eltrombopag). Subjects is receiving treatment ...

  10. Kimberly G. Blumenthal, M.D. - Mayo Clinic Faculty Profiles

    ... resistance and healthcare-associated infections, and lowers healthcare costs. These strategies have been implemented across multiple hospital systems and ...